Results 151 to 160 of about 1,273 (212)

Neurofibromatosis type 1 adult surveillance form for Austria. [PDF]

Wien Klin Wochenschr
Sunder-Plassmann V, Azizi AA, Farschtschi S, Gruber R, Hutterer M, Ladurner V, Röhl C, Welponer T, Bergmeister-Berghoff AS.   +8 more
europepmc   +1 more source

Neural crest gene regulatory networks as drivers of development, diversification and disease. [PDF]

Nat Rev Mol Cell Biol
Stundl J, Desingu Rajan AR, Bronner ME.
europepmc   +1 more source

Low-grade malignant peripheral nerve sheath tumour presenting as retroperitoneal spindle cell neoplasm. [PDF]

J Int Med Res
Karn M, Mahato BK, Ojha L, Thapa Y, Bhatta S, Sharma S, Chapagain S, Ranabhat S, Neupane BR, Shrestha DM.   +9 more
europepmc   +1 more source

The Lack of Ad Hoc Neuropsychological Assessment in Adults with Neurofibromatosis: A Systematic Review. [PDF]

J Clin Med
Maresca G, Bonanno C, Veneziani I, Buono VL, Latella D, Quartarone A, Marino S, Formica C.   +7 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Neurofibromatoses

Hematology/Oncology Clinics of North America, 2022
The neurofibromatoses are a group of genetic disorders that cause development of nervous system tumors as well as various other tumor and systemic manifestations. Neurofibromatosis type 1 is the most prevalent of these conditions and has the most variable phenotype and highest risk of malignant tumor formation.
Scott R Plotkin, Justin T Jordan
exaly   +3 more sources

Neurofibromatoses

Journal of Neuropathology and Experimental Neurology, 2009
Anat Stemmer-Rachamimov
exaly   +2 more sources